These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 18631907

  • 1. Total endoscopic management (TEM approach) of children with non-compliant neuropathic bladder: a preliminary report.
    Neel KF, Salem M, Soliman S.
    J Pediatr Urol; 2008 Apr; 4(2):124-6. PubMed ID: 18631907
    [Abstract] [Full Text] [Related]

  • 2. Total endoscopic and anal irrigation management approach to noncompliant neuropathic bladder in children: a good alternative.
    Neel KF.
    J Urol; 2010 Jul; 184(1):315-8. PubMed ID: 20488484
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of a minimally invasive surgical approach to manage persistent high-grade vesicoureteric reflux post successful augmentation cystoplasty of patients with non-compliant bladder.
    Alsowayan O, Barham A, Alqarni N, Alnazari M, Alsakharni M, Ewida T, Trbay M, Elderwy AA, Alhazmi H, Neel KF.
    J Pediatr Urol; 2015 Apr; 11(2):60.e1-4. PubMed ID: 25294281
    [Abstract] [Full Text] [Related]

  • 4. [Minimally invasive, safe treatment of the neurogenic bladder with botulinum-A-toxin in children with myelomeningocele].
    Lusuardi L, Nader A, Koen M, Schrey A, Schindler M, Riccabona M.
    Aktuelle Urol; 2004 Feb; 35(1):49-53. PubMed ID: 14997415
    [Abstract] [Full Text] [Related]

  • 5. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.
    Mascarenhas F, Cocuzza M, Gomes CM, Leão N.
    Neurourol Urodyn; 2008 Feb; 27(4):311-4. PubMed ID: 17914742
    [Abstract] [Full Text] [Related]

  • 6. Intravesical injection of botulinum toxin type A: management of neuropathic bladder and bowel dysfunction in children with myelomeningocele.
    Kajbafzadeh AM, Moosavi S, Tajik P, Arshadi H, Payabvash S, Salmasi AH, Akbari HR, Nejat F.
    Urology; 2006 Nov; 68(5):1091-6; discussion 1096-7. PubMed ID: 17113899
    [Abstract] [Full Text] [Related]

  • 7. Concomitant repeated intravesical injections of botulinum toxin-type A and laparoscopic antegrade continence enema; a new solution for an old problem.
    Kajbafzadeh A, Mahboubi AH, Payabvash S.
    BJU Int; 2009 May; 103(9):1248-54. PubMed ID: 19154454
    [Abstract] [Full Text] [Related]

  • 8. Repeated intradetrusor botulinum toxin type A in children with neurogenic bladder due to myelomeningocele.
    Altaweel W, Jednack R, Bilodeau C, Corcos J.
    J Urol; 2006 Mar; 175(3 Pt 1):1102-5. PubMed ID: 16469632
    [Abstract] [Full Text] [Related]

  • 9. [Decisional criteria in the management of vesico-ureteral reflux in children with congenital neurogenic bladder].
    Steyaert H, Gebran S, Moscovici J, Juskiewenski S.
    Prog Urol; 1996 Feb; 6(1):76-80. PubMed ID: 8624531
    [Abstract] [Full Text] [Related]

  • 10. Botulinum-A toxin: solo treatment for neuropathic noncompliant bladder.
    Neel KF, Soliman S, Salem M, Seida M, Al-Hazmi H, Khatab A.
    J Urol; 2007 Dec; 178(6):2593-7; discussion 2597-8. PubMed ID: 17945300
    [Abstract] [Full Text] [Related]

  • 11. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
    Giannantoni A, Mearini E, Del Zingaro M, Porena M.
    Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
    [Abstract] [Full Text] [Related]

  • 12. Botulinum A toxin urethral sphincter injection in children with nonneurogenic neurogenic bladder.
    Mokhless I, Gaafar S, Fouda K, Shafik M, Assem A.
    J Urol; 2006 Oct; 176(4 Pt 2):1767-70; discussion 1770. PubMed ID: 16945643
    [Abstract] [Full Text] [Related]

  • 13. Repeated Botulinum-A toxin injection in the treatment of neuropathic bladder dysfunction and poor bladder compliance in children with myelomeningocele.
    Horst M, Weber DM, Bodmer C, Gobet R.
    Neurourol Urodyn; 2011 Nov; 30(8):1546-9. PubMed ID: 21674597
    [Abstract] [Full Text] [Related]

  • 14. Postpubertal urodynamic and upper urinary tract changes in children with conservatively treated myelomeningocele.
    Almodhen F, Capolicchio JP, Jednak R, El Sherbiny M.
    J Urol; 2007 Oct; 178(4 Pt 1):1479-82. PubMed ID: 17706702
    [Abstract] [Full Text] [Related]

  • 15. Repeated botulinum-A toxin injections in the treatment of myelodysplastic children and patients with spinal cord injuries with neurogenic bladder dysfunction.
    Akbar M, Abel R, Seyler TM, Bedke J, Haferkamp A, Gerner HJ, Möhring K.
    BJU Int; 2007 Sep; 100(3):639-45. PubMed ID: 17532858
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A for neurogenic detrusor overactivity due to spinal cord lesions in children: a retrospective study of seven cases.
    Do Ngoc Thanh C, Audry G, Forin V.
    J Pediatr Urol; 2009 Dec; 5(6):430-6. PubMed ID: 19577520
    [Abstract] [Full Text] [Related]

  • 17. [Prospective study of the clinical and urodynamic results of intradetrusor botulinum toxin injections for the treatment of neurogenic overactive bladder].
    Bentaleb Y, Castel-Lacanal E, Sallusto F, De Boissezon X, Malavaud B, Marque P, Rischmann P, Gamé X.
    Prog Urol; 2008 Jul; 18(7):449-55. PubMed ID: 18602606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Botulinum injection is useless on fibrotic neuropathic bladders.
    Tiryaki S, Yagmur I, Parlar Y, Ozel K, Akyildiz C, Avanoglu A, Ulman I.
    J Pediatr Urol; 2015 Feb; 11(1):27.e1-4. PubMed ID: 25448589
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.